Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

Clinical trial NCT06110195 · TERMINATED

Trial details

NCT number: NCT06110195
Sponsor: University of Chicago
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancer Head and Neck Neoplasms Squamous Cell Carcinoma of Head and Neck

Start date: 2024-01-24
Primary completion: 2025-05-12
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.